Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

PerspectiveFree Preview

Measuring the Value of Prescription Drugs

List of authors.
  • Peter J. Neumann, Sc.D.,
  • and Joshua T. Cohen, Ph.D.

Escalating drug prices have spawned a flurry of initiatives designed to help physicians, payers, and patients understand the value of new therapies and make better choices about their use. But these efforts have revealed numerous analytic and implementation challenges.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

This article was published on November 18, 2015, and updated on November 20, 2015, at NEJM.org.

Author Affiliations

From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston.

Print Subscriber? Activate your online access.